methylprednisolone has been researched along with Central Nervous System Toxoplasmosis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kan, FK; Pagalavan, L | 1 |
| Hayashi, Y; Hino, M; Inaba, A; Inoue, A; Koh, H; Nakamae, H; Nakane, T; Nakashima, Y; Nanno, S; Nishimoto, M; Okamura, H; Shimono, T | 1 |
2 other study(ies) available for methylprednisolone and Central Nervous System Toxoplasmosis
| Article | Year |
|---|---|
Cerebral toxoplasmosis in systemic lupus erythematosus following intravenous methylprednisolone.
Topics: Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Toxoplasmosis, Cerebral | 2011 |
Cerebral toxoplasmosis after umbilical cord blood transplantation diagnosed by the detection of anti-toxoplasma specific IgM antibody in cerebrospinal fluid.
Topics: Antibodies, Protozoan; Biomarkers; Clindamycin; Cord Blood Stem Cell Transplantation; Early Diagnosis; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunoglobulin M; Methylprednisolone; Middle Aged; Myelodysplastic Syndromes; Tacrolimus; Toxoplasma; Toxoplasmosis, Cerebral; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2014 |